| Dr Steven A Sobeck, MD | |
|
430 E Division St, Fond Du Lac, WI 54935-4560 | |
| (920) 926-8340 | |
| Not Available |
| Full Name | Dr Steven A Sobeck |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 12 Years |
| Location | 430 E Division St, Fond Du Lac, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831456714 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 61614-20 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Agnes Hospital | Fond du lac, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Agnesian Healthcare Inc | 1658289624 | 319 |
News Archive
Researchers at Johns Hopkins have found a better way to create induced pluripotent stem (iPS) cells-adult cells reprogrammed with the properties of embryonic stem cells-from a small blood sample. This new method, described last week in Cell Research, avoids creating DNA changes that could lead to tumor formation.
Helsinn Healthcare S.A. and Zealand Pharma A/S jointly announce that Helsinn has started a Phase IIB clinical dose-finding trial of elsiglutide for the prevention of chemotherapy-induced diarrhea (CID). The first patients out of a planned total of 600 patients with colorectal cancer treated with chemotherapy have been dosed in the trial.
The Board of Regents of the American College of Surgeons (ACS) presented Mary H. McGrath, MD, MPH, FACS, of San Francisco, CA, with the College's 2011 Distinguished Service Award on October 23, during its Annual Clinical Congress in San Francisco.
Clear Guide Medical has signed a Cooperative Research and Development Agreement with the U.S. Army Institute of Surgical Research to test the physician performance enhancements possible when using the Clear Guide ONE and the VisiTIP needles.
According to a new major study one in eight children born with HIV becomes resistant to the three main classes of drugs used to suppress the virus within five years of starting treatment. This is the first major study that looks at drug resistance in 1,000 European children born with HIV. It raises questions about the suitability of anti-retroviral drugs for the young.
› Verified 6 days ago
| Entity Name | Agnesian Healthcare Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346228541 PECOS PAC ID: 1658289624 Enrollment ID: O20031104000263 |
News Archive
Researchers at Johns Hopkins have found a better way to create induced pluripotent stem (iPS) cells-adult cells reprogrammed with the properties of embryonic stem cells-from a small blood sample. This new method, described last week in Cell Research, avoids creating DNA changes that could lead to tumor formation.
Helsinn Healthcare S.A. and Zealand Pharma A/S jointly announce that Helsinn has started a Phase IIB clinical dose-finding trial of elsiglutide for the prevention of chemotherapy-induced diarrhea (CID). The first patients out of a planned total of 600 patients with colorectal cancer treated with chemotherapy have been dosed in the trial.
The Board of Regents of the American College of Surgeons (ACS) presented Mary H. McGrath, MD, MPH, FACS, of San Francisco, CA, with the College's 2011 Distinguished Service Award on October 23, during its Annual Clinical Congress in San Francisco.
Clear Guide Medical has signed a Cooperative Research and Development Agreement with the U.S. Army Institute of Surgical Research to test the physician performance enhancements possible when using the Clear Guide ONE and the VisiTIP needles.
According to a new major study one in eight children born with HIV becomes resistant to the three main classes of drugs used to suppress the virus within five years of starting treatment. This is the first major study that looks at drug resistance in 1,000 European children born with HIV. It raises questions about the suitability of anti-retroviral drugs for the young.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Steven A Sobeck, MD 420 E Division St, Fond Du Lac, WI 54935-4560 Ph: (920) 926-8340 | Dr Steven A Sobeck, MD 430 E Division St, Fond Du Lac, WI 54935-4560 Ph: (920) 926-8340 |
News Archive
Researchers at Johns Hopkins have found a better way to create induced pluripotent stem (iPS) cells-adult cells reprogrammed with the properties of embryonic stem cells-from a small blood sample. This new method, described last week in Cell Research, avoids creating DNA changes that could lead to tumor formation.
Helsinn Healthcare S.A. and Zealand Pharma A/S jointly announce that Helsinn has started a Phase IIB clinical dose-finding trial of elsiglutide for the prevention of chemotherapy-induced diarrhea (CID). The first patients out of a planned total of 600 patients with colorectal cancer treated with chemotherapy have been dosed in the trial.
The Board of Regents of the American College of Surgeons (ACS) presented Mary H. McGrath, MD, MPH, FACS, of San Francisco, CA, with the College's 2011 Distinguished Service Award on October 23, during its Annual Clinical Congress in San Francisco.
Clear Guide Medical has signed a Cooperative Research and Development Agreement with the U.S. Army Institute of Surgical Research to test the physician performance enhancements possible when using the Clear Guide ONE and the VisiTIP needles.
According to a new major study one in eight children born with HIV becomes resistant to the three main classes of drugs used to suppress the virus within five years of starting treatment. This is the first major study that looks at drug resistance in 1,000 European children born with HIV. It raises questions about the suitability of anti-retroviral drugs for the young.
› Verified 6 days ago
Matthew Ryan Purcell, DO Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 430 E Division St, Fond Du Lac, WI 54935 Phone: 812-243-9158 | |
Anthony K Strigenz, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 430 E Division St, Fond Du Lac, WI 54935 Phone: 920-926-2300 | |
Jacqueline Lee Bogan, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 430 E Division St, Fond Du Lac, WI 54935 Phone: 920-929-2300 Fax: 608-262-6247 | |
Dr. Jacob M Waidelich, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 430 E Division St, Fond Du Lac, WI 54935 Phone: 920-926-8340 Fax: 920-926-8370 | |
Ilya A Khotimsky, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 430 E Division St, Fond Du Lac, WI 54935 Phone: 920-929-2300 | |
Lawrence R Bellmore Iii, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 430 E Division St, Fond Du Lac, WI 54935 Phone: 920-926-8332 Fax: 920-926-8370 | |
Henry T Chang, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 430 E Division St, Fond Du Lac, WI 54935 Phone: 920-926-2300 |